A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Friedreich Ataxia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Scientia Clinical Research Ltd, Sydney, New South Wales, Australia
Contact: Study coordinator (Varlli Scott) · Varlli.scott@mcri.edu.au · +613 8341 6228
Doherty Clinical Trials, East Melbourne, Victoria, Australia
Contact: Study coordinator (Varlli Scott) · Varlli.scott@mcri.edu.au · +613 8341 6228
Nucleus Network, Melbourne, Victoria, Australia
Contact: Study coordinator (Varlli Scott) · Varlli.scott@mcri.edu.au · +613 8341 6228

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

Friedreich Ataxia

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Gainesville, United States

A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies

Friedreich Ataxia

Abroad (travel likely)Recruiting

Morrisville, United States

A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

Friedreich Ataxia

Abroad (travel likely)RecruitingPHASE3

Los Angeles, United States · Gainesville, United States

Clinical Course Of Disease In Participants With FA-CM

Friedreich Ataxia · Cardiomyopathy

Abroad (travel likely)Recruiting

La Jolla, United States · Tampa, United States